高性能烷烃脱氢铂系催化剂
Search documents
凯立新材关联交易获通过 氢能业务进入客户评测阶段
Jing Ji Guan Cha Wang· 2026-02-13 03:21
Core Viewpoint - The company has received shareholder approval for related party transactions and is advancing its hydrogen energy business, which is currently in the customer evaluation phase, while the high-performance catalyst project is undergoing equipment debugging and has attracted interest from a well-known private equity firm [1][2][3][4][5]. Group 1: Related Party Transactions - The company held its first extraordinary shareholders' meeting on January 16, 2026, where it approved the proposal for expected related party transactions for 2026, with a total estimated amount of 171.3 million yuan, involving procurement, sales, and labor exchanges [2]. Group 2: Business Progress - The hydrogen energy business is progressing steadily, with ongoing projects in hydrogen production, storage, and applications. As of the first half of 2025, the "hydrogen energy special" project has entered the batch trial production and promotion phase, currently in the customer evaluation stage [3]. Group 3: Project Development - The high-performance alkane dehydrogenation platinum catalyst research and development project is in the batch trial production and production line construction phase, with equipment debugging and trial production ongoing. The estimated annual demand for this project is approximately 1,400 tons, which could bring additional revenue to the company [4]. Group 4: Institutional Research - A well-known private equity firm, Hongcheng Investment, conducted a telephone survey of the company on February 3, 2026, focusing on PVC catalyst sales, BDO catalyst mass promotion, PDH catalyst progress, and the hydrogen energy business. Such surveys often reflect market interest in the company [5].
凯立新材(688269.SH):在研项目高性能烷烃脱氢铂系催化剂研发正处于批量试产/产线建设
Ge Long Hui· 2026-02-03 13:57
Core Viewpoint - The company, Kaili New Materials (688269.SH), is currently in the process of batch trial production and production line construction for its high-performance platinum-based dehydrogenation catalyst project, with equipment debugging and trial production stages ongoing [1] Group 1 - The estimated annual usage of the platinum-based dehydrogenation catalyst is approximately 1,400 tons [1]
凯立新材:在研项目高性能烷烃脱氢铂系催化剂研发正处于批量试产/产线建设
Ge Long Hui· 2026-02-03 13:52
Core Viewpoint - The company is in the process of batch trial production and production line construction for its high-performance platinum-based dehydrogenation catalyst project, with equipment debugging and pilot production currently underway [1] Group 1 - The estimated annual usage of the platinum-based dehydrogenation catalyst is around 1,400 tons [1]
【私募调研记录】正圆投资调研道通科技、凯立新材
Zheng Quan Zhi Xing· 2025-08-19 00:14
Group 1: Daotong Technology - Daotong Technology is developing an end-to-end payment solution in the AI + charging business, supporting multiple payment methods and exploring stablecoin payments and RW financing [1] - The AI and software business operates on a subscription model, providing various value-added services to enhance software revenue and renewal rates [1] - The growth of the TPMS business is driven by policy benefits and market demand, with significant global aftermarket replacement demand [1] - The AI + inspection business has been implemented in oilfield inspections, achieving a fully autonomous process closure and cluster collaborative response [1] Group 2: Kaili New Materials - In Q2, Kaili New Materials experienced significant profit growth, but revenue declined due to changes in business structure [2] - In the first half of the year, the revenue breakdown showed that the fine chemicals sector accounted for 70.48%, basic chemicals for 25.35%, and environmental new energy for 2.90% [2] - Sales of mercury-free PVC catalysts reached 258 tons, with 366 tons in hand orders, and sales of mercury-free PVC catalysts increased by 113.22% [2] - The high-performance platinum-based dehydrogenation catalyst is in batch trial production, while the hydrogenated nitrile rubber project is in the debugging phase, with applications in oilfields and the automotive industry [2] - The pharmaceutical segment saw a sales increase of 49.26%, with expectations for continued growth in the global pharmaceutical market and R&D service demand [2] - The company plans to optimize resources by deregistering Kaili Platinum, which has not commenced operations [2] - The fair value change loss is primarily due to the initiation of gold leasing business [2]